FDA issued Emergency Use Authorization for convalescent plasma as potential promising COVIDﾖ19 treatment
On Aug. 23, 2020, the FDA issued an emergency use authorization (EUA) for investigational convalescent plasma for the…
Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
CDC published ACIP 2020-21 influenza vaccination recommendations
On Aug. 21, 2020, the CDC published Immunization Practices Advisory Committee (ACIP) 2020-21 influenza vaccination recommendations. Routine annual…
JAMA reported on effect of remdesivir vs standard care on clinical status in patients with moderate COVID-19
On Aug. 21, 2020, JAMA reported that hospitalized patients with moderate COVID-19 randomized to a 5-day course of…
Failure to ﾑflatten the curveﾒ may kill more people than we thought
On Aug. 21, 2020, research by the University of Minnesota and the University of Washington found that every…
CureVac and EC advanced discussions to supply up to 405 million doses of potential mRNA-based COVID-19 vaccine
On Aug. 20, 2020, CureVac and the European Commission (EC) concluded exploratory talks outlining an Advanced Purchase Agreement…
Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeutics
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
GT Biopharma updated development of TriKE(TM) therapeutic for treatment of COVID-19 infection
On Aug. 20, 2020, GT Biopharma and Cytovance announced a collaboration agreement whereby Cytovance will providing drug development…
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
Oragenics signed a process development and manufacturing agreement with Avid Bioservices for Coronavirus vaccine
On Aug. 20, 2020, Oragenics and Avid Bioservices announced a process development and drug substance manufacturing agreement. Avid…
Evidence suggested children could play a larger role in community spread of COVID-19
On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…
OpGen announced CE-IVD Mark and commercial launch in EU of molecular diagnostic with PULB for detection of COVID-19
On Aug. 20, 2020, OpGen announced that its subsidiary Curetis GmbH had obtained the CE mark certification in…
Pfizer and BioNTech shared positive early data on lead mRNA vaccine candidate BNT162b2 against COVID-19
On Aug. 20, 2020, Pfizer and BioNTech shared additional Phase 1 safety and immunogenicity data from their U.S….
JAMA reported on evaluation for SARS-CoV-2 in breast milk from infected women
On Aug. 19, 2020, JAMA reported that to date, SARS-CoV-2 has not been isolated from breast milk, and…
NIH imposed ‘outrageous’ conditions on resuming coronavirus grants
On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…
CDC data showed disproportionate COVID-19 impact in American Indian/Alaska Native populations
On Aug. 19, 2020, the CDC released a new study that specifically examines how COVID-19 is affecting American…
Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…
Accelerate Diagnostics announced FDA Emergency Use Authorization for COVID-19 antibody testing system
On Aug. 19, 2020, Accelerate Diagnostics and BioCheck announced that the FDA had issued an Emergency Use Authorization…
Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaﾮ SARS…
BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditions
On Aug. 19, 2018, BioNexus KC announced it had been awarded a $42,900 grant from the Health Forward…
Bio-Techne and Leica Biosystems are acceleratied disease research with RNAscopeﾙ COVID-19 probes and the BOND RX
On Aug. 19, 2020, Bio-Techne in partnership with Leica Biosystems, announced the automation of RNAscopeﾙ COVID-19 probes on…
Experimental COVID-19 vaccine prevented severe disease in mice
On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billion
On Aug. 19, 2020, Johnson & Johnson announced an agreement to acquire Momenta Pharmaceuticals, a company that discovers…
UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…
Spike protein of the new corona virus is more flexible than expected
On Aug. 18, 2020, scientists from the Max Planck Institute for Biophysics, the Paul Ehrlich Institute, the European…
HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response
On Aug. 18, 2020, researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of…
Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19
On Aug. 18, 2020, Regeneron and Roche announced that they had joined forces in the fight against COVID-19…
NIH delivered $43 million to support convalescent plasma clinical trial
On Aug. 18, 2020, the National Institutes of Health awarded Albert Einstein College of Medicine and Montefiore a…
Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia
On Aug. 18, 2020, Vanda Pharma reported that interim analysis showed tradipitant may accelerate clinical improvement in SARS-CoV-2…